Do you want to read an article? Please log in or register.
Effect of normobaric hypoxia on exercise performance in pulmonary hypertension - randomized trial
Pulmonary Hypertension
RECOMMENDED
Related content
COMMENTED
Pulmonary Hypertension
Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial
Eur Respir J.
Ulrich S, Saxer S, Hasler ED, Schwarz EI, Schneider SR, Furian M, Bader PR, Lichtblau M, Bloch KE
doi: 10.1183/13993003.002762019.
COMMENTED
Pulmonary Hypertension
ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension
Eur Respir J.
Grünig E, Eichstaedt C, Barberà JA, Benjamin N, Blanco I, Bossone E, Cittadini A, Coghlan G, Corris P, D'Alto M, D'Andrea A, Delcroix M, de Man F, Gaine S, Ghio S, Gibbs S, Gumbiene L, Howard LS, Johnson M, Jurevičienė E, Kiely DG, Kovacs G, MacKenzie A, Marra AM, McCaffrey N, McCaughey P, Naeije R, Olschewski H, Pepke-Zaba J, Reis A, Santos M, Saxer S, Tulloh RM, Ulrich S, Noordegraaf AV, Peacock AJ
doi: 10.1183/13993003.00332-2018.
RECOMMENDED
COPD
Effect of nocturnal oxygen therapy on exercise performance of COPD patients at 2048 m: data from a randomized clinical trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Sci Rep
Gutweniger S, Latshang TD, Aeschbacher SS, Huber F, Flueck D, Lichtblau M, Ulrich S, Hasler ED, Scheiwiller PM, Ulrich S, Bloch KE, Furian M
doi: 10.1038/s41598-021-98395-w
RECOMMENDED
Pulmonary Hypertension
Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial
Lancet Respir Med.
Sadushi-Kolici R, Jansa P, Kopec G, Torbicki A, Skoro-Sajer N, Campean IA, Halank M, Simkova I, Karlocai K, Steringer-Mascherbauer R, Samarzija M, Salobir B, Klepetko W, Lindner J, Lang IM
doi: 10.1016/S2213-2600
RECOMMENDED
COPD
The effect of carotid chemoreceptor inhibition on exercise tolerance in chronic obstructive pulmonary disease: A randomized-controlled crossover trial
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Med.
Phillips DB, Collins SÉ, Bryan TL, Wong EYL, McMurtry MS, Bhutani M, Stickland MK
doi: 10.1016/j.rmed.2019.105815.
RECOMMENDED
Pulmonary Hypertension
Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
Respir Res.
Marra AM, Halank M, Benjamin N, Bossone E, Cittadini A, Eichstaedt CA, Egenlauf B, Harutyunova S, Fischer C, Gall H, Ghofrani HA, Hoeper MM, Lange TJ, Olsson KM, Klose H, Grünig E
doi: 10.1186/s12931-018-0957-y.
RECOMMENDED
Further Publications
Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med.
Scott JV, Garnett CE, Kanwar MK, Stockbridge NL, Benza RL
doi: 10.1164/rccm.202002-0357OC.
RECOMMENDED
Asthma
Effect of a combined exercise program on physical fitness, lung function, and quality of life in patients with controlled asthma and exercise symptoms: A randomized controlled trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Pediatr Pulmonol.
Sanz-Santiago V, Diez-Vega I, Santana-Sosa E, Lopez Nuevo C, Iturriaga Ramirez T, Vendrusculo FM, Donadio MVF, Villa Asensi JR, Pérez-Ruiz M
doi: 10.1002/ppul.24798.
RECOMMENDED
Pulmonary Fibrosis
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
JAMA
Martinez FJ, Yow E, Flaherty KR, Snyder LD, Durheim MT, Wisniewski SR, Sciurba FC, Raghu G, Brooks MM, Kim DY, Dilling DF, Criner GJ, Kim H, Belloli EA, Nambiar AM, Scholand MB, Anstrom KJ, Noth I, CleanUP-IPF Investigators of the Pulmonary Trials Cooperative.
doi: 10.1001/jama.2021.4956